Clinical Trial Update: The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating tirzepatide in people with overweight/obesity and coronary artery disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Coronary Artery Disease
• Coronary Microvascular Dysfunction
• Obesity
• Stable Angina

Drugs mentioned

• MOUNJARO (tirzepatide)

Snippet

Sponsor: Tina Vilsbøll | Conditions: Coronary Artery Disease, Coronary Microvascular Dysfunction | Phase 4 | Status: RECRUITING